A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses.

A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses.

Item
http://www.wikidata.org/entity/Q30226740
Effect of vaccine administration modality on immunogenicity and efficacy.Clinical vaccine development for H5N1 influenza.Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects.Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial.Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine.Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.Immunobiology of influenza vaccinesInfluenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans.Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Adjuvanted influenza vaccines.Development and pilot testing of a text message vaccine reminder system for use during an influenza pandemic.
P2860

A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses.

Item
http://www.wikidata.org/entity/Q30226740
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A phase III, randomized, open- ...... etween first and second doses.
@ast
A phase III, randomized, open- ...... etween first and second doses.
@en
type
label
A phase III, randomized, open- ...... etween first and second doses.
@ast
A phase III, randomized, open- ...... etween first and second doses.
@en
prefLabel
A phase III, randomized, open- ...... etween first and second doses.
@ast
A phase III, randomized, open- ...... etween first and second doses.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
A phase III, randomized, open- ...... etween first and second doses.
@en
P2093
P304
P31
P356
10.1016/S0149-2918(11)00024-5
P433
P478
P577
P698